Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Booking | London | Consumer Cyclicals | Hotels & Entertainment Services | 42.2% | £137.03B | 35.3x | 11.95 | 414,207.69 | 98% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NVIDIA | London | 39.3% | £2.60T | 52.3x | 0.24 | 10,485.88 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Ashtead Group | London | Industrials | Professional & Commercial Services | 23.3% | £22.73B | 18.5x | -3.52 | 5,196 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.6% Upside | Upgrade to Pro+ | |
Gilead Sciences | London | Healthcare | Pharmaceuticals | 18.5% | £90.46B | 906.9x | -9.4 | 7,139.79 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
London Stock Exchange | London | Financial | Investment Banking & Investment Services | 11.6% | £60.50B | 90.2x | -2.33 | 11,390 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.2% Upside | Upgrade to Pro+ | |
Ferrovial | London | Industrials | Construction & Engineering | 10% | £24.55B | 38.3x | 0.18 | 3,364.82 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BHP Group PLC | London | Basic Materials | Metals & Mining | 7.1% | £103.43B | 16.5x | -0.43 | 2,046 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.3% Upside | Upgrade to Pro+ | |
Investor AB | London | Financial | Investment Holding Companies | 4.4% | £65.70B | 4.4x | 0.04 | 1,364.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adobe | London | -2% | £159.55B | 38.6x | 7.23 | 36,791.92 | 100,000% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Novartis | London | Healthcare | Pharmaceuticals | -8.5% | £156.16B | 11.4x | 0.13 | 7,780.49 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eiffage SA | London | Industrials | Construction & Engineering | -8.5% | £6.89B | 8.2x | 1.05 | 7,203.35 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novo Nordisk L | London | Healthcare | Pharmaceuticals | -11.3% | £371.53B | 35.7x | 1.34 | 8,436.37 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck & Co Inc | London | Healthcare | Pharmaceuticals | -12.6% | £205.17B | 21.3x | 0.13 | 8,185.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AstraZeneca | London | Healthcare | Pharmaceuticals | -15.8% | £162.50B | 31.6x | 3.31 | 10,468 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ |